Literature DB >> 3088390

Isolation and characterization of apolipoproteins A-I, A-II, and A-IV.

H B Brewer, R Ronan, M Meng, C Bishop.   

Abstract

A number of different analytical techniques are now available for the isolation of apoA-I, apoA-II, and apoA-IV. The choice of a particular technique is dependent on the instrumentation available, and the quantity of isolated apolipoprotein required. The isolation and characterization of the separate isoforms and the precursor isoproteins of the individual apolipoproteins are detailed, and methods for the evaluation of the purity of the separate apolipoproteins presented. A method for the evaluation of apolipoproteins in plasma is now available which permits the identification of structural variants of plasma apolipoproteins in patients with dyslipoproteinemias.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3088390     DOI: 10.1016/0076-6879(86)28070-2

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  34 in total

1.  Expression of scavenger receptor class B type 1 (SR-BI) promotes microvillar channel formation and selective cholesteryl ester transport in a heterologous reconstituted system.

Authors:  E Reaven; S Leers-Sucheta; A Nomoto; S Azhar
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

2.  Diverse range of small peptides associated with high-density lipoprotein.

Authors:  Glen L Hortin; Rong-Fong Shen; Brian M Martin; Alan T Remaley
Journal:  Biochem Biophys Res Commun       Date:  2005-12-27       Impact factor: 3.575

3.  Modified apolipoprotein (apo) A-I by artificial sweetener causes severe premature cellular senescence and atherosclerosis with impairment of functional and structural properties of apoA-I in lipid-free and lipid-bound state.

Authors:  Wookju Jang; Nam Ho Jeoung; Kyung-Hyun Cho
Journal:  Mol Cells       Date:  2011-04-21       Impact factor: 5.034

4.  High-dose consumption of NaCl resulted in severe degradation of lipoproteins associated with hyperlipidemia, hyperglycemia, and infertility via impairment of testicular spermatogenesis.

Authors:  Eun-Young Lee; Kyung-Hyun Cho
Journal:  Toxicol Res (Camb)       Date:  2016-01-08       Impact factor: 3.524

5.  Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred.

Authors:  A T Remaley; S Rust; M Rosier; C Knapper; L Naudin; C Broccardo; K M Peterson; C Koch; I Arnould; C Prades; N Duverger; H Funke; G Assman; M Dinger; M Dean; G Chimini; S Santamarina-Fojo; D S Fredrickson; P Denefle; H B Brewer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

6.  Seminal vesicle autoantigen, a novel phospholipid-binding protein secreted from luminal epithelium of mouse seminal vesicle, exhibits the ability to suppress mouse sperm motility.

Authors:  Y H Huang; S T Chu; Y H Chen
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

7.  In vivo metabolism of proapolipoprotein A-I in Tangier disease.

Authors:  D Bojanovski; R E Gregg; L A Zech; M S Meng; C Bishop; R Ronan; H B Brewer
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

8.  A facile method for isolation of recombinant human apolipoprotein A-I from E. coli.

Authors:  Nikita Ikon; Jennifer Shearer; Jianfang Liu; Jesse J Tran; ShiBo Feng; Ayako Kamei; Jennifer A Beckstead; Robert S Kiss; Paul M Weers; Gang Ren; Robert O Ryan
Journal:  Protein Expr Purif       Date:  2017-03-20       Impact factor: 1.650

9.  Pressure perturbation calorimetry of apolipoproteins in solution and in model lipoproteins.

Authors:  Sangeeta Benjwal; Olga Gursky
Journal:  Proteins       Date:  2010-04

10.  In vivo metabolism of a mutant form of apolipoprotein A-I, apo A-IMilano, associated with familial hypoalphalipoproteinemia.

Authors:  P Roma; R E Gregg; M S Meng; R Ronan; L A Zech; G Franceschini; C R Sirtori; H B Brewer
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.